Статті в журналах з теми "Estrogen Therapeutic use"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Estrogen Therapeutic use".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Fillit, Howard. "Future Therapeutic Developments of Estrogen Use." Journal of Clinical Pharmacology 35, no. 9S (September 1995): 25S—28S. http://dx.doi.org/10.1002/j.1552-4604.1995.tb04144.x.
Martin-Jiménez, Cynthia, Diana Milena Gaitán-Vaca, Natalia Areiza, Valentina Echeverria, Ghulam Md Ashraf, Janneth González, Amirhossein Sahebkar, Luis Miguel Garcia-Segura, and George E. Barreto. "Astrocytes Mediate Protective Actions of Estrogenic Compounds after Traumatic Brain Injury." Neuroendocrinology 108, no. 2 (November 4, 2018): 142–60. http://dx.doi.org/10.1159/000495078.
Santen, Richard J., Risa Kagan, Corrado J. Altomare, Barry Komm, Sebastian Mirkin, and Hugh S. Taylor. "Current and Evolving Approaches to Individualizing Estrogen Receptor-Based Therapy for Menopausal Women." Journal of Clinical Endocrinology & Metabolism 99, no. 3 (March 1, 2014): 733–47. http://dx.doi.org/10.1210/jc.2013-3680.
Macciò, Antonio, and Clelia Madeddu. "Obesity, Inflammation, and Postmenopausal Breast Cancer: Therapeutic Implications." Scientific World JOURNAL 11 (2011): 2020–36. http://dx.doi.org/10.1100/2011/806787.
Mitra, Saikat, Mashia Subha Lami, Avoy Ghosh, Rajib Das, Trina Ekawati Tallei, Fatimawali, Fahadul Islam, et al. "Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?" Cancers 14, no. 3 (February 1, 2022): 759. http://dx.doi.org/10.3390/cancers14030759.
Gérard, Céline, Mélanie Mestdagt, Ekaterine Tskitishvili, Laudine Communal, Anne Gompel, Elisabete Silva, Jean-François Arnal, et al. "Combined Estrogenic and Antiestrogenic Properties of Estetrol on Breast Cancer may provide a Safe Therapeutic Window for the Treatment of Menopausal Symptoms." Journal of SAFOMS 3, no. 1 (2015): 31–33. http://dx.doi.org/10.5005/jsafoms-3-1-31.
Hwang, Wu Jeong, Tae Young Lee, Nahrie Suk Kim, and Jun Soo Kwon. "The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders." International Journal of Molecular Sciences 22, no. 1 (December 31, 2020): 373. http://dx.doi.org/10.3390/ijms22010373.
Zhao, Zhuo, Hao Wang, Jewell A. Jessup, Sarah H. Lindsey, Mark C. Chappell, and Leanne Groban. "Role of estrogen in diastolic dysfunction." American Journal of Physiology-Heart and Circulatory Physiology 306, no. 5 (March 1, 2014): H628—H640. http://dx.doi.org/10.1152/ajpheart.00859.2013.
Farkas, Szidónia, Adrienn Szabó, Anita Emőke Hegyi, Bibiána Török, Csilla Lea Fazekas, Dávid Ernszt, Tamás Kovács, and Dóra Zelena. "Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions." Biomedicines 10, no. 4 (April 6, 2022): 861. http://dx.doi.org/10.3390/biomedicines10040861.
Sulaymanova, R. T. "EXPERIMENTAL MODELS OF TRANSGENERATIONAL EFFECTS OF THE INFLUENCE OF ESTROGENS ON THE MORPHOLOGY OF REPRODUCTIVE ORGANS IN POSTNATAL ONTOGENESIS." Morphological newsletter 27, no. 1 (March 30, 2019): 36–44. http://dx.doi.org/10.20340/mv-mn.19(27).01.36-44.
Normanno, Nicola, Massimo Di Maio, Ermelinda De Maio, Antonella De Luca, Andrea de Matteis, Antonio Giordano, Francesco Perrone, and _. _. "Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer." Endocrine-Related Cancer 12, no. 4 (December 2005): 721–47. http://dx.doi.org/10.1677/erc.1.00857.
Elloso, M. Merle, Kristen Phiel, Ruth A. Henderson, Heather A. Harris, and Steven J. Adelman. "Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands." Journal of Endocrinology 185, no. 2 (May 2005): 243–52. http://dx.doi.org/10.1677/joe.1.06063.
Manyonda, Isaac, Vikram S Talaulikar, Roxanna Pirhadi, and Joseph Onwude. "Progestogens are the problem in hormone replacement therapy: Time to reappraise their use." Post Reproductive Health 26, no. 1 (December 25, 2019): 26–31. http://dx.doi.org/10.1177/2053369119876490.
Carroll, Kelli J., Michael C. Dovey, Claire C. Cutting, James M. Harris, Lea M. Vedder, Wolfram Goessling, and Trista E. North. "Estrogen Receptors 1 and 2 Have Stage-Specific Effects on Hematopoietic Stem Cell Regulation In Zebrafish." Blood 116, no. 21 (November 19, 2010): 1617. http://dx.doi.org/10.1182/blood.v116.21.1617.1617.
Petrie, Whitney K., Megan K. Dennis, Chelin Hu, Donghai Dai, Jeffrey B. Arterburn, Harriet O. Smith, Helen J. Hathaway, and Eric R. Prossnitz. "G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth." Obstetrics and Gynecology International 2013 (2013): 1–17. http://dx.doi.org/10.1155/2013/472720.
Yakushevskaya, O. V. "Continuous combined low-dose hormone replacement therapy in perimenopause: an algorithm of choice." Meditsinskiy sovet = Medical Council, no. 3 (April 15, 2021): 113–18. http://dx.doi.org/10.21518/2079-701x-2021-3-113-118.
Carroll, Kelli J., Michael C. Dovey, Claire C. Cutting, Lea Vedder Sheward, James M. Harris, Wolfram Goessling, and Trista E. North. "Hematopoietic Stem Cell Formation in Zebrafish Is Regulated in a Temporally Distinct Manner by Estrogen Receptor 2." Blood 118, no. 21 (November 18, 2011): 1268. http://dx.doi.org/10.1182/blood.v118.21.1268.1268.
Kareva, Kareva E. N., and Smetnik A. A. Smetnik. "Estrogen-like and antioxidant properties of resveratrol in clinical pharmacology and therapeutic use." Akusherstvo i ginekologiia 12_2021 (December 24, 2021): 37–48. http://dx.doi.org/10.18565/aig.2021.12.37-48.
Acharya, Asha, Ila Das, Des Chandhok, and Tapas Saha. "Redox Regulation in Cancer: A Double-edged Sword with Therapeutic Potential." Oxidative Medicine and Cellular Longevity 3, no. 1 (2010): 23–34. http://dx.doi.org/10.4161/oxim.3.1.10095.
Compston, Juliet E. "Sex Steroids and Bone." Physiological Reviews 81, no. 1 (January 1, 2001): 419–47. http://dx.doi.org/10.1152/physrev.2001.81.1.419.
Benagiano, Giuseppe, and Ivo Brosens. "The Endometrium in Adenomyosis." Women's Health 8, no. 3 (May 2012): 301–12. http://dx.doi.org/10.2217/whe.12.8.
Velez, Maria A., Timothy F. Burns, and Laura P. Stabile. "The estrogen pathway as a modulator of response to immunotherapy." Immunotherapy 11, no. 13 (September 2019): 1161–76. http://dx.doi.org/10.2217/imt-2019-0024.
Kuznetsova, I. V. "Transition period of estrogen-progestogen hormone therapy." Medical alphabet 3, no. 25 (November 19, 2019): 6–10. http://dx.doi.org/10.33667/2078-5631-2019-3-25(400)-6-10.
Biggar, Robert J. "Molecular Pathways: Digoxin Use and Estrogen-Sensitive Cancers—Risks and Possible Therapeutic Implications: Figure 1." Clinical Cancer Research 18, no. 8 (February 24, 2012): 2133–37. http://dx.doi.org/10.1158/1078-0432.ccr-11-1389.
Zhao, Hong, Ling Zhou, Anna Junjie Shangguan, and Serdar E. Bulun. "Aromatase expression and regulation in breast and endometrial cancer." Journal of Molecular Endocrinology 57, no. 1 (July 2016): R19—R33. http://dx.doi.org/10.1530/jme-15-0310.
Foster, Paul A., L. W. Lawrence Woo, Barry V. L. Potter, Michael J. Reed, and Atul Purohit. "The Use of Steroid Sulfatase Inhibitors as a Novel Therapeutic Strategy Against Hormone-Dependent Endometrial Cancer." Endocrinology 149, no. 8 (May 1, 2008): 4035–42. http://dx.doi.org/10.1210/en.2008-0223.
Zhao, Liqin, Zisu Mao та Roberta Diaz Brinton. "A Select Combination of Clinically Relevant Phytoestrogens Enhances Estrogen Receptor β-Binding Selectivity and Neuroprotective Activities in Vitro and in Vivo". Endocrinology 150, № 2 (1 лютого 2009): 770–83. http://dx.doi.org/10.1210/en.2008-0715.
Kuznetsova, I. V., L. V. Evsyukova, and V. A. Konovalov. "Combined oral contraception: is there a resource for increased use?" Medical Council, no. 12 (July 29, 2018): 146–51. http://dx.doi.org/10.21518/2079-701x-2018-12-146-151.
Gucalp, Ayca, and Tiffany A. Traina. "Triple-Negative Breast Cancer: Adjuvant Therapeutic Options." Chemotherapy Research and Practice 2011 (June 21, 2011): 1–13. http://dx.doi.org/10.1155/2011/696208.
Hahn, S. E., L. A. da Cruz, D. Sayegh, A. Ferry, K. O’Reilly, D. S. Pereira, D. B. Rubinstein, H. Findlay, and D. S. Young. "Therapeutic monoclonal antibodies target phenotypically-differing human breast cancer." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 13510. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.13510.
Monaco, Alessandra, Fabrizio Licitra, Martina Di Gisi, Giovanni Galasso, Marzia Di Donato, Pia Giovannelli, Antimo Migliaccio та Gabriella Castoria. "ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities". Endocrines 2, № 3 (13 вересня 2021): 356–65. http://dx.doi.org/10.3390/endocrines2030033.
shen, Tian, Helia Nasrollahi Sanchez, Hong Zan, and Paolo Casali. "Short-chain fatty acid HDAC inhibitor-mediated downregulation of AID expression and class switch DNA recombination is relieved by estrogen through modulation of selected microRNAs." Journal of Immunology 196, no. 1_Supplement (May 1, 2016): 127.12. http://dx.doi.org/10.4049/jimmunol.196.supp.127.12.
Cannataro, Roberto, and Erika Cione. "Nutritional Supplements and Lipedema: Scientific and Rational Use." Nutraceuticals 2, no. 4 (October 3, 2022): 270–77. http://dx.doi.org/10.3390/nutraceuticals2040020.
Kim, Kyung Hee, Derek Toomre, and Jeffrey R. Bender. "Splice isoform estrogen receptors as integral transmembrane proteins." Molecular Biology of the Cell 22, no. 22 (November 15, 2011): 4415–23. http://dx.doi.org/10.1091/mbc.e11-05-0416.
Chen, Shuhua, Jon Nilsen, and Roberta Diaz Brinton. "Dose and Temporal Pattern of Estrogen Exposure Determines Neuroprotective Outcome in Hippocampal Neurons: Therapeutic Implications." Endocrinology 147, no. 11 (November 1, 2006): 5303–13. http://dx.doi.org/10.1210/en.2006-0495.
Yukalchuk, D. Yu, D. M. Ponomarenko, T. N. Yukalchuk, S. S. Sidorova, A. V. Shevchuk, and A. M. Novopashin. "The Use of Alpelisib in Metastatic Estrogen-Receptor-Positive HER2/Neu-Negative Breast Cancer." Effective Pharmacotherapy 18, no. 13 (April 25, 2022): 121–16. http://dx.doi.org/10.33978/2307-3586-2022-18-13-12-16.
Oualla, Karima, Heba M. El-Zawahry, Banu Arun, James M. Reuben, Wendy A. Woodward, Heba Gamal El-Din, Bora Lim, Nawfel Mellas, Naoto T. Ueno, and Tamer M. Fouad. "Novel therapeutic strategies in the treatment of triple-negative breast cancer." Therapeutic Advances in Medical Oncology 9, no. 7 (June 13, 2017): 493–511. http://dx.doi.org/10.1177/1758834017711380.
Bitirim, Ceylan V., Zeynep B. Ozer, and Kamil C. Akcali. "Estrogen receptor alpha regulates the expression of adipogenic genes genetically and epigenetically in rat bone marrow-derived mesenchymal stem cells." PeerJ 9 (September 10, 2021): e12071. http://dx.doi.org/10.7717/peerj.12071.
Ghuge, Rahul B., Prashant R. Murumkar, Kailash M. Choudhary, Karan D. Joshi, Monica Chauhan, Rahul R. Barot, and Mange R. Yadav. "Development of Steroidal Aromatase Inhibitors as Potential Anti-breast Cancer Agents." Current Enzyme Inhibition 16, no. 1 (May 4, 2020): 45–62. http://dx.doi.org/10.2174/1573408016666200212094804.
Downs, William V., Edward L. Perkins, William E. Burak, and Himangshu S. Bose. "ODP433 An increased in AIPB expression in Triple Negative (ER-/PR-/Her2-) Breast Tumors reduces estradiol synthesis." Journal of the Endocrine Society 6, Supplement_1 (November 1, 2022): A671. http://dx.doi.org/10.1210/jendso/bvac150.1388.
Wu, Malinda, Neha Arora, Viranuj Sueblinvong, William R. Hunt, and Vin Tangpricha. "Estrogen Supplementation Is Associated With Higher Quality of Life Scores in Women With Cystic Fibrosis." Journal of the Endocrine Society 5, Supplement_1 (May 1, 2021): A732. http://dx.doi.org/10.1210/jendso/bvab048.1489.
Vorobiof, Daniel A. "Recent advances in the medical treatment of breast cancer." F1000Research 5 (November 29, 2016): 2786. http://dx.doi.org/10.12688/f1000research.9619.1.
Gunther, Jillian R., Yuhong Du, Eric Rhoden, Iestyn Lewis, Brian Revennaugh, Terry W. Moore, Sung Hoon Kim, Raymond Dingledine, Haian Fu, and John A. Katzenellenbogen. "A Set of Time-Resolved Fluorescence Resonance Energy Transfer Assays for the Discovery of Inhibitors of Estrogen Receptor-Coactivator Binding." Journal of Biomolecular Screening 14, no. 2 (February 2009): 181–93. http://dx.doi.org/10.1177/1087057108329349.
Li, Ang. "An Overview of Tumor Necrosis Factor-α on Pathophysiological Mechanisms, Relevant Therapeutic Status in Breast Cancer". Highlights in Science, Engineering and Technology 8 (17 серпня 2022): 472–80. http://dx.doi.org/10.54097/hset.v8i.1201.
Ray, Rinki, Christine M. Herring, Troy A. Markel, Paul R. Crisostomo, Meijing Wang, Brent Weil, Tim Lahm, and Daniel R. Meldrum. "Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 294, no. 5 (May 2008): R1498—R1503. http://dx.doi.org/10.1152/ajpregu.00897.2007.
Thabet, Romany H., Adel A. Gomaa, Laila M. Matalqah, and Erin M. Shalaby. "Vitamin D: an essential adjuvant therapeutic agent in breast cancer." Journal of International Medical Research 50, no. 7 (July 2022): 030006052211138. http://dx.doi.org/10.1177/03000605221113800.
Komal S, Harikrishnan N, Gejalakshmi S, Kayalvizhi S, Hemamalini Baskaran, Priyanka J, Mohan Kumar A, and Sriram GM. "Novel herbs and drugs for endometriosis management: A review on current and futuristic therapies." International Journal of Research in Pharmaceutical Sciences 12, no. 2 (May 8, 2021): 1404–14. http://dx.doi.org/10.26452/ijrps.v12i2.4699.
Ciesielska, Aleksandra, Aida Kusiak, Agata Ossowska, and Magdalena Emilia Grzybowska. "Changes in the Oral Cavity in Menopausal Women—A Narrative Review." International Journal of Environmental Research and Public Health 19, no. 1 (December 27, 2021): 253. http://dx.doi.org/10.3390/ijerph19010253.
Yu, Xinge, Angela C. Weyand, and Jordan A. Shavit. "Surprisingly Rapid Onset of Estrogen-Induced Venous Thrombosis in an Animal Model." Blood 132, Supplement 1 (November 29, 2018): 418. http://dx.doi.org/10.1182/blood-2018-99-120325.
Lopez-Munoz, E., N. Garcia-Hernandez, R. I. Penaloza-Espinosa, M. E. Gomez-Del Toro, G. Zarco-Espinosa, S. Barroso-Bravo, F. Salamanca-Gomez, and D. J. Arenas-Aranda. "”BIK/NBK Gene Expression as a Possible Marker of Circulating Breast Cancer Cells in Blood“." Open Biomarkers Journal 4, no. 1 (October 14, 2011): 8–14. http://dx.doi.org/10.2174/1875318301104010008.